Related references
Note: Only part of the references are listed.Stereotactic Ablative Radiotherapy for the Management of Liver Metastases from Neuroendocrine Neoplasms: A Preliminary Study
John Monte Hudson et al.
NEUROENDOCRINOLOGY (2022)
Neuroendocrine tumor G3 of bronchopulmonary origin and its classification
Atsuko Kasajima et al.
PATHOLOGY INTERNATIONAL (2022)
Local control after stereotactic body radiotherapy of centrally located lung tumours
A. A. Khalil et al.
ACTA ONCOLOGICA (2021)
Nordic guidelines 2021 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2021)
Indications of Peptide Receptor Radionuclide Therapy (PRRT) in Gastroenteropancreatic and Pulmonary Neuroendocrine Tumors: An Updated Review
Baptiste Camus et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Outcomes after high-dose radiation in the management of neuroendocrine neoplasms
Katherine S. Chen et al.
PLOS ONE (2021)
Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
Johannes Hofland et al.
ENDOCRINE REVIEWS (2020)
The 2019 WHO classification of tumours of the digestive system
Iris D. Nagtegaal et al.
HISTOPATHOLOGY (2020)
Surgical resection versus stereotactic body radiation therapy in early stage bronchopulmonary large cell neuroendocrine carcinoma
Herman Lo et al.
THORACIC CANCER (2020)
Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y
M. Pavel et al.
ANNALS OF ONCOLOGY (2020)
Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy
Yoshitaka Honma et al.
CANCER MEDICINE (2020)
External Beam Radiotherapy in the Treatment of Gastroenteropancreatic Neuroendocrine Tumours: A Systematic Review
D. L. Chan et al.
CLINICAL ONCOLOGY (2018)
Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry
Anand Mahadevan et al.
RADIATION ONCOLOGY (2018)
Not only stem cells, but also mature cells, particularly neuroendocrine cells, may develop into tumours: time for a paradigm shift
Helge L. Waldum et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Efficacy of radiotherapy for primary tumor in patients with unresectable pancreatic neuroendocrine tumors
Tomoyuki Iwata et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2017)
Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
J. Strosberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer
Matthias Guckenberger et al.
RADIOTHERAPY AND ONCOLOGY (2017)
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
Arvind Dasari et al.
JAMA ONCOLOGY (2017)
Diagnosis and treatment of bronchopulmonary neuroendocrine tumours: State of the art
Elizaveta Mitkina Tabaksblat et al.
ACTA ONCOLOGICA (2016)
Diagnosis and management of gastrointestinal neuroendocrine tumors: An evidence-based Canadian consensus
Simron Singh et al.
CANCER TREATMENT REVIEWS (2016)
Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study
H. Sorbye et al.
ANNALS OF ONCOLOGY (2013)
Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; Systematic review and comparison with a surgical cohort
Francesca Solda et al.
RADIOTHERAPY AND ONCOLOGY (2013)
Share Paper
